TPEx is scheduled to hold a TPEx Listing Review Committee meeting on October 17, 2019 to review the listing application of Crystalvue Medical Corporation (stock code: 6527)

:::HOME > Press Releases > Press Release Detail

TPEx is scheduled to hold a TPEx Listing Review Committee meeting on October 17, 2019 to review the listing application of Crystalvue Medical Corporation (stock code: 6527)

Date:2019/10/09

Crystalvue Medical Corporation is applying for listing on TPEx. At the time of application, the company has capital in the amount of NT$214,200 thousand, its chairman is William Wang, and its recommending securities firms include KGI Securities and Yuanta Securities.

Revenue, net profit after tax and earnings per share of the applicant reports for FY 2018 were NT$606,308 thousand, NT$69,886 thousand, and NT$3.23 respectively. Revenue, net profit after tax and earnings per share of the applicant reports for first half of FY 2019 were NT$333,410 thousand, NT$48,513 thousand, and NT$2.25 respectively.

TOP

Taipei Exchange

TPEx is scheduled to hold a TPEx Listing Review Committee meeting on October 17, 2019 to review the listing application of Crystalvue Medical Corporation (stock code: 6527)